Pharmacists in Durant, Oklahoma


29 Pharmacists found in Durant
male pharmacist

Larry D Graham


Pharmacist
1026 Radio Rd, Durant, OK 74701
580-924-7425    

male pharmacist

Dr. Mark Patrick Glenn, PHARMD


Pharmacist
3712 W Main St, Durant, OK 74701
580-924-5112     580-924-4551

male pharmacist

Mr. Mark S Villines, DPH., RPH.


Pharmacist
1026 Radio Rd, Durant, OK 74701
580-924-7425     580-924-0525



male pharmacist

Matthew Cochran


Pharmacist
1801 Chukkahina, Durant, OK 74701
580-920-2100    

male pharmacist

Michael Trent Macon, PHARMD


Pharmacist
102 Waldron Dr, Durant, OK 74701
580-920-2211    

female pharmacist

Michele Oller, DPH


Pharmacist
1026 Radio Rd, Durant, OK 74701
580-924-7425     580-924-0525

male pharmacist

Nelson Scott Edgeman, PHARMD


Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
1800 W University Blvd, Durant, OK 74701
580-931-2033    

male pharmacist

Nikolas Allen Stajduhar, PHARMD, BCPS


Pharmacist
1801 Chukkahina, Durant, OK 74701
580-920-2100    

female pharmacist

Peiqing Zheng


Pharmacist
1250 W Main St, Durant, OK 74701
580-920-9945    

male pharmacist

Ryan Williams, PHARM. D.


Pharmacist
1026 Radio Rd, Durant, OK 74701
580-924-7425     580-924-0525

female pharmacist

Sabrina Edgeman, PHARMD


Pharmacist
311 N Washington Ave, Durant, OK 74701
580-924-3784    

female pharmacist

Dr. Steffany Lea Sawyers-rambo, RPH


Pharmacist
311 N Washington Ave, Durant, OK 74701
580-924-3784     580-920-0048

male pharmacist

Zane Seay, PHARMD


Pharmacist
1026 Radio Rd, Durant, OK 74701
580-924-7425    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.